Published in Clin Microbiol Rev on January 01, 2008
Human schistosomiasis. Lancet (2014) 4.00
"Manifesto" for advancing the control and elimination of neglected tropical diseases. PLoS Negl Trop Dis (2010) 2.22
Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat Rev Microbiol (2010) 2.10
In Vivo MRI Assessment of Hepatic and Splenic Disease in a Murine Model of Schistosmiasis. PLoS Negl Trop Dis (2015) 2.02
Schistosomiasis in the People's Republic of China: the era of the Three Gorges Dam. Clin Microbiol Rev (2010) 1.82
Schistosomiasis in Africa: an emerging tragedy in our new global health decade. PLoS Negl Trop Dis (2009) 1.72
Africa's 32 cents solution for HIV/AIDS. PLoS Negl Trop Dis (2009) 1.68
Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. PLoS Negl Trop Dis (2008) 1.58
Vaccines to combat the neglected tropical diseases. Immunol Rev (2011) 1.55
Trick or treat: the role of vaccines in integrated schistosomiasis control. PLoS Negl Trop Dis (2008) 1.54
The protective role of antibody responses during Mycobacterium tuberculosis infection. Clin Exp Immunol (2009) 1.48
Preventive chemotherapy as a strategy for elimination of neglected tropical parasitic diseases: endgame challenges. Philos Trans R Soc Lond B Biol Sci (2013) 1.47
Th2 cell hyporesponsiveness during chronic murine schistosomiasis is cell intrinsic and linked to GRAIL expression. J Clin Invest (2009) 1.43
RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening. PLoS Negl Trop Dis (2010) 1.32
CD4 memory T cells: what are they and what can they do? Semin Immunol (2009) 1.29
Successful parasitism of vector snail Biomphalaria glabrata by the human blood fluke (trematode) Schistosoma mansoni: a 2009 assessment. Mol Biochem Parasitol (2009) 1.24
Schistosomiasis vaccines. Hum Vaccin (2011) 1.23
Hepatic and intestinal schistosomiasis: review. J Adv Res (2013) 1.20
To B or not to B: B cells and the Th2-type immune response to helminths. Trends Immunol (2010) 1.16
Tissue specific profiling of females of Schistosoma japonicum by integrated laser microdissection microscopy and microarray analysis. PLoS Negl Trop Dis (2009) 1.10
Transcriptional changes in Schistosoma mansoni during early schistosomula development and in the presence of erythrocytes. PLoS Negl Trop Dis (2010) 1.10
The Syk kinase SmTK4 of Schistosoma mansoni is involved in the regulation of spermatogenesis and oogenesis. PLoS Pathog (2010) 1.08
Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni. Parasite Immunol (2009) 1.06
Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model. Vaccine (2009) 1.04
Human schistosomiasis: clinical perspective: review. J Adv Res (2013) 1.03
Schistosomiasis vaccine discovery using immunomics. Parasit Vectors (2010) 1.03
Profiles of small non-coding RNAs in Schistosoma japonicum during development. PLoS Negl Trop Dis (2011) 1.02
Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis. Parasit Vectors (2011) 1.02
Increased vascularity in cervicovaginal mucosa with Schistosoma haematobium infection. PLoS Negl Trop Dis (2011) 1.02
Schistosoma mansoni population structure and persistence after praziquantel treatment in two villages of Bahia, Brazil. Int J Parasitol (2011) 1.02
Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis. PLoS One (2012) 1.01
Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2. PLoS Negl Trop Dis (2012) 1.01
Glycoconjugates in host-helminth interactions. Front Immunol (2013) 1.01
Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine. Parasitol Res (2009) 1.00
Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus. Infect Immun (2010) 1.00
Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine. J Infect Dis (2010) 0.99
In vitro activities of trioxaquines against Schistosoma mansoni. Antimicrob Agents Chemother (2009) 0.99
Inconsistent protective efficacy and marked polymorphism limits the value of Schistosoma japonicum tetraspanin-2 as a vaccine target. PLoS Negl Trop Dis (2011) 0.98
Immune events associated with high level protection against Schistosoma japonicum infection in pigs immunized with UV-attenuated cercariae. PLoS One (2010) 0.96
The formin-homology protein SmDia interacts with the Src kinase SmTK and the GTPase SmRho1 in the gonads of Schistosoma mansoni. PLoS One (2009) 0.95
An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas. PLoS Pathog (2014) 0.93
Schistosoma comparative genomics: integrating genome structure, parasite biology and anthelmintic discovery. Trends Parasitol (2011) 0.92
Identifying host species driving transmission of schistosomiasis japonica, a multihost parasite system, in China. Proc Natl Acad Sci U S A (2013) 0.91
Worms and the treatment of inflammatory bowel disease: are molecules the answer? Clin Dev Immunol (2008) 0.91
Induction of type 2 responses by schistosome worms during prepatent infection. J Infect Dis (2010) 0.90
Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity. PLoS One (2014) 0.90
The Schistosoma mansoni phylome: using evolutionary genomics to gain insight into a parasite's biology. BMC Genomics (2012) 0.89
SmCL3, a gastrodermal cysteine protease of the human blood fluke Schistosoma mansoni. PLoS Negl Trop Dis (2009) 0.89
Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice. Int J Infect Dis (2010) 0.89
Novel therapeutic and prevention approaches for schistosomiasis: review. J Adv Res (2012) 0.89
Kicking in the Guts: Schistosoma mansoni Digestive Tract Proteins are Potential Candidates for Vaccine Development. Front Immunol (2015) 0.88
Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infection. BMC Immunol (2010) 0.88
Transmission risks of schistosomiasis japonica: extraction from back-propagation artificial neural network and logistic regression model. PLoS Negl Trop Dis (2013) 0.88
Molecular diagnosis of Schistosoma infections in urine samples of school children in Ghana. Am J Trop Med Hyg (2013) 0.87
Schistosoma mansoni venom allergen like proteins present differential allergic responses in a murine model of airway inflammation. PLoS Negl Trop Dis (2012) 0.87
Proportions of CD4+ memory T cells are altered in individuals chronically infected with Schistosoma haematobium. Sci Rep (2012) 0.87
Local immune responses of the Chinese water buffalo, Bubalus bubalis, against Schistosoma japonicum larvae: crucial insights for vaccine design. PLoS Negl Trop Dis (2013) 0.87
Structure-function analysis of apical membrane-associated molecules of the tegument of schistosome parasites of humans: prospects for identification of novel targets for parasite control. Br J Pharmacol (2014) 0.86
Prevention and control of schistosomiasis: a current perspective. Res Rep Trop Med (2014) 0.86
TLR3 modulates immunopathology during a Schistosoma mansoni egg-driven Th2 response in the lung. Eur J Immunol (2008) 0.86
The schistosomiasis research agenda--what now? PLoS Negl Trop Dis (2008) 0.86
Endomyocardial fibrosis associated with Schistosoma haematobium infection. Ghana Med J (2014) 0.86
Suppression of the Insulin Receptors in Adult Schistosoma japonicum Impacts on Parasite Growth and Development: Further Evidence of Vaccine Potential. PLoS Negl Trop Dis (2015) 0.85
Hepatobiliary Schistosomiasis. J Clin Transl Hepatol (2014) 0.85
Computational vaccinology: an important strategy to discover new potential S. mansoni vaccine candidates. J Biomed Biotechnol (2011) 0.85
Serological screening of the Schistosoma mansoni adult worm proteome. PLoS Negl Trop Dis (2014) 0.85
Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models. Vaccine (2011) 0.85
Trioxaquine PA1259 alkylates heme in the blood-feeding parasite Schistosoma mansoni. Antimicrob Agents Chemother (2011) 0.84
Imaging schistosomes in vivo. FASEB J (2009) 0.84
Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidases. Front Genet (2014) 0.84
Longevity of Sm-p80-specific antibody responses following vaccination with Sm-p80 vaccine in mice and baboons and transplacental transfer of Sm-p80-specific antibodies in a baboon. Parasitol Res (2014) 0.84
Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model. Front Immunol (2015) 0.83
Induction of Protective Immune Responses Against Schistosomiasis haematobium in Hamsters and Mice Using Cysteine Peptidase-Based Vaccine. Front Immunol (2015) 0.83
Application of RNAi to Genomic Drug Target Validation in Schistosomes. PLoS Negl Trop Dis (2015) 0.83
Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment. Clin Microbiol Rev (2014) 0.83
Alterations in peripheral blood B cell subsets and dynamics of B cell responses during human schistosomiasis. PLoS Negl Trop Dis (2013) 0.82
Efficacy of praziquantel in the treatment of Schistosoma haematobium infection among school-age children in rural communities of Abeokuta, Nigeria. Infect Dis Poverty (2014) 0.82
Schistosome Vaccine Adjuvants in Preclinical and Clinical Research. Vaccines (Basel) (2014) 0.82
Laboratory assessment of the molluscicidal and cercariacidal activities of Balanites aegyptiaca. Asian Pac J Trop Biomed (2013) 0.82
Upregulated expression of cytotoxicity-related genes in IFN-γ knockout mice with Schistosoma japonicum infection. J Biomed Biotechnol (2011) 0.81
Oral delivery of the Sj23LHD-GST antigen by Salmonella typhimurium type III secretion system protects against Schistosoma japonicum infection in mice. PLoS Negl Trop Dis (2011) 0.81
Lipid core peptide targeting the cathepsin D hemoglobinase of Schistosoma mansoni as a component of a schistosomiasis vaccine. Hum Vaccin Immunother (2013) 0.81
Immunization with recombinantly expressed glycan antigens from Schistosoma mansoni induces glycan-specific antibodies against the parasite. Glycobiology (2014) 0.81
Schistosomiasis vaccines: where do we stand? Parasit Vectors (2016) 0.81
Combined TLR7/8 and TLR9 ligands potentiate the activity of a Schistosoma japonicum DNA vaccine. PLoS Negl Trop Dis (2013) 0.80
The nature and combination of subunits used in epitope-based Schistosoma japonicum vaccine formulations affect their efficacy. Parasit Vectors (2010) 0.80
Protein kinase C and extracellular signal-regulated kinase regulate movement, attachment, pairing and egg release in Schistosoma mansoni. PLoS Negl Trop Dis (2014) 0.80
Proteomic analysis of schistosomiasis japonica vaccine candidate antigens recognized by UV-attenuated cercariae-immunized porcine serum IgG2. Parasitol Res (2013) 0.80
Partial regulatory T cell depletion prior to schistosomiasis vaccination does not enhance the protection. PLoS One (2012) 0.80
Helminth parasite proteomics: from experimental models to human infections. Parasitology (2012) 0.80
TLR2 directing PD-L2 expression inhibit T cells response in Schistosoma japonicum infection. PLoS One (2013) 0.79
Scanning electron microscopy of the human low-density lipoprotein interaction with the tegument of Schistosoma mansoni. Parasitol Res (2011) 0.79
Development of a schistosomiasis vaccine. Expert Rev Vaccines (2016) 0.79
S. mansoni Trapping in Lungs Contributes to Resistance to Reinfection. Front Immunol (2015) 0.79
Tracking the odysseys of juvenile schistosomes to understand host interactions. PLoS Negl Trop Dis (2008) 0.79
Discovery of novel Schistosoma japonicum antigens using a targeted protein microarray approach. Parasit Vectors (2014) 0.79
Partially Protective Immunity Induced by a 20 kDa Protein Secreted by Trichinella spiralis Stichocytes. PLoS One (2015) 0.78
A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis. BMC Infect Dis (2016) 0.78
Human schistosomiasis. Lancet (2006) 10.87
Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet (2005) 9.45
Schistosomiasis. N Engl J Med (2002) 7.48
The global status of schistosomiasis and its control. Acta Trop (2000) 6.89
The immunobiology of schistosomiasis. Nat Rev Immunol (2002) 6.07
Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med (1991) 5.04
Conquering schistosomiasis in China: the long march. Acta Trop (2005) 3.77
Prevention and control of cystic echinococcosis. Lancet Infect Dis (2007) 3.64
The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol (2005) 3.35
Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century. Clin Microbiol Rev (2001) 2.85
Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS (2006) 2.83
Immunopathology of schistosomiasis. Immunol Cell Biol (2006) 2.74
Katayama syndrome. Lancet Infect Dis (2007) 2.71
Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat Genet (2003) 2.66
Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med (2006) 2.59
Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PLoS Med (2007) 2.39
Immunopathogenesis of schistosomiasis. Immunol Rev (2004) 2.28
Schistosomiasis: challenges for control, treatment and drug resistance. Curr Opin Infect Dis (2006) 2.24
CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol (2004) 2.03
Transmission control for schistosomiasis - why it matters now. Trends Parasitol (2006) 2.02
Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource. Nat Genet (2003) 2.01
Coinfection with Plasmodium falciparum and schistosoma haematobium: protective effect of schistosomiasis on malaria in senegalese children? Am J Trop Med Hyg (2005) 1.82
Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol Cell Proteomics (2005) 1.81
Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect Immun (2006) 1.76
Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Expert Rev Anti Infect Ther (2006) 1.75
Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth. Mol Biochem Parasitol (2005) 1.73
Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J Immunol (2006) 1.73
Immunodiagnosis and its role in schistosomiasis control in China: a review. Acta Trop (2005) 1.72
Implementation of human schistosomiasis control: Challenges and prospects. Adv Parasitol (2006) 1.69
Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis. Vaccine (2005) 1.69
TGF-beta signaling controls embryo development in the parasitic flatworm Schistosoma mansoni. PLoS Pathog (2007) 1.68
A drug-based intervention study on the importance of buffaloes for human Schistosoma japonicum infection around Poyang Lake, People's Republic of China. Am J Trop Med Hyg (2006) 1.67
The tegument surface membranes of the human blood parasite Schistosoma mansoni: a proteomic analysis after differential extraction. Proteomics (2006) 1.63
Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? Trends Parasitol (2005) 1.59
Mathematical modelling of schistosomiasis japonica: comparison of control strategies in the People's Republic of China. Acta Trop (2002) 1.56
Identification of paramyosin as schistosome antigen recognized by intradermally vaccinated mice. Science (1986) 1.54
Schistosome membrane proteins as vaccines. Int J Parasitol (2006) 1.52
Optimizing gene suppression in schistosomes using RNA interference. Mol Biochem Parasitol (2007) 1.47
Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection. Infect Immun (1993) 1.46
The cytoskeleton and motor proteins of human schistosomes and their roles in surface maintenance and host-parasite interactions. Bioessays (2004) 1.42
Schistosoma mansoni infection in eosinophil lineage-ablated mice. Blood (2006) 1.42
Hookworm vaccines: past, present, and future. Lancet Infect Dis (2006) 1.41
Schistosomiasis co-infection in humans influences inflammatory markers in uncomplicated Plasmodium falciparum malaria. Parasite Immunol (2005) 1.40
A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis. J Immunol (1987) 1.39
Schistosomiasis vaccine:research to development. Parasitol Today (1998) 1.38
Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease. Immunol Rev (2004) 1.37
Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol (2005) 1.37
Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Trends Parasitol (2005) 1.36
Vaccines against the zoonotic trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola gigantica. Parasitology (2006) 1.35
Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans. Infect Immun (2006) 1.33
Gene-based vaccines: recent technical and clinical advances. Trends Mol Med (2006) 1.32
Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen. Proc Natl Acad Sci U S A (1988) 1.32
Priming of the immune response by schistosome eggs. Parasite Immunol (2005) 1.29
The immunobiology of Th1 polarization in high-pathology schistosomiasis. Immunol Rev (2004) 1.27
A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proc Natl Acad Sci U S A (1996) 1.25
Treatment of Schistosoma mansoni infection increases helminth-specific type 2 cytokine responses and HIV-1 loads in coinfected Ugandan adults. J Infect Dis (2005) 1.24
Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms. J Immunol (1999) 1.24
Large water management projects and schistosomiasis control, Dongting Lake region, China. Emerg Infect Dis (2007) 1.23
Mass spectrometric analysis of the Schistosoma mansoni tegumental sub-proteome. J Proteome Res (2005) 1.23
Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens. J Infect Dis (2005) 1.22
Schistosoma mansoni: identification and analysis of an mRNA and a gene encoding superoxide dismutase (Cu/Zn). Exp Parasitol (1988) 1.22
Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoni. Trans R Soc Trop Med Hyg (2005) 1.21
Blueprint for schistosomiasis vaccine development. Acta Trop (2002) 1.21
Calpain is the target antigen of a Th1 clone that transfers protective immunity against Schistosoma mansoni. J Immunol (1996) 1.20
Prospects for development of a transmission blocking vaccine against Schistosoma japonicum. Parasite Immunol (2005) 1.19
Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice. Clin Exp Immunol (2005) 1.18
Development of a vaccine against Schistosoma japonicum in China: a review. Acta Trop (2005) 1.18
Natural versus drug-induced resistance in Schistosoma mansoni infection. Parasitol Today (2000) 1.17
Genetic manipulation of schistosomes. Int J Parasitol (2007) 1.17
Vaccine delivery methods using viral vectors. Mol Pharm (2007) 1.17
T-helper-2 cytokine responses to Sj97 predict resistance to reinfection with Schistosoma japonicum. Infect Immun (2006) 1.15
Characterization of Ca(2+)-dependent neutral protease (calpain) from human blood flukes, Schistosoma mansoni. Biochim Biophys Acta (1993) 1.15
Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice. Vaccine (2001) 1.14
Receptor for Fc on the surfaces of schistosomes. Infect Immun (2001) 1.14
Proteomic analysis of the tetraspanin web using LC-ESI-MS/MS and MALDI-FTICR-MS. Proteomics (2006) 1.13
In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens. Acta Trop (2003) 1.12
Human immune responses to Schistosoma mansoni vaccine candidate antigens. Infect Immun (2000) 1.12
Fasciola antigens as vaccines against fascioliasis and schistosomiasis. J Helminthol (2005) 1.12
Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment. Am J Trop Med Hyg (2000) 1.11
'Oming in on schistosomes: prospects and limitations for post-genomics. Trends Parasitol (2006) 1.11
Lack of antigen-specific Th1 response alters granuloma formation and composition in Schistosoma mansoni-infected MyD88-/- mice. Eur J Immunol (2005) 1.10
The schistosomiasis problem in the Philippines: a review. Parasitol Int (2004) 1.10
Schistosomiasis and HIV-1 infection in rural Zimbabwe: implications of coinfection for excretion of eggs. J Infect Dis (2005) 1.10
Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies. Clin Exp Immunol (2006) 1.09
Schistosome transcriptomes: new insights into the parasite and schistosomiasis. Trends Mol Med (2004) 1.09
Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies? Trends Parasitol (2005) 1.09
Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigens. J Immunol (2006) 1.09
Characterization of cDNA clones encoding a novel calcium-activated neutral proteinase from Schistosoma mansoni. J Biol Chem (1991) 1.08
A 14-kDa Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins. J Biol Chem (1991) 1.08
Effects of concomitant Schistosoma haematobium infection on the serum cytokine levels elicited by acute Plasmodium falciparum malaria infection in Malian children. Infect Immun (2006) 1.07
The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil. Trans R Soc Trop Med Hyg (1990) 1.06
Integrating transcriptome, proteome and glycome analyses of Schistosoma biology. Trends Parasitol (2007) 1.06
T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase. J Immunol (1994) 1.05
Exposure to malaria affects the regression of hepatosplenomegaly after treatment for Schistosoma mansoni infection in Kenyan children. BMC Med (2004) 1.05
Protection against Schistosoma mansoni infection with a recombinant baculovirus-expressed subunit of calpain. Vaccine (1997) 1.05
Update on paramyosin in parasitic worms. Parasitol Int (2005) 1.04
Interferon-gamma production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni. Trans R Soc Trop Med Hyg (1995) 1.04
Schistosoma mansoni: the developmental regulation and immunolocalization of antioxidant enzymes. Exp Parasitol (1997) 1.04
Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet (2006) 15.08
Hookworm infection. N Engl J Med (2004) 4.58
Liver fluke induces cholangiocarcinoma. PLoS Med (2007) 3.89
Whole-genome sequence of Schistosoma haematobium. Nat Genet (2012) 2.91
Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med (2006) 2.59
Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Trop (2010) 2.23
Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat Rev Microbiol (2010) 2.10
The tumorigenic liver fluke Opisthorchis viverrini--multiple pathways to cancer. Trends Parasitol (2012) 1.86
Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J Immunol (2010) 1.65
Vaccines to combat the neglected tropical diseases. Immunol Rev (2011) 1.55
Digestive proteases of blood-feeding nematodes. Trends Parasitol (2003) 1.48
Unlocking the transcriptomes of two carcinogenic parasites, Clonorchis sinensis and Opisthorchis viverrini. PLoS Negl Trop Dis (2010) 1.46
Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative. Int J Parasitol (2003) 1.46
A granulin-like growth factor secreted by the carcinogenic liver fluke, Opisthorchis viverrini, promotes proliferation of host cells. PLoS Pathog (2009) 1.45
Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals. FASEB J (2005) 1.44
A multi-enzyme cascade of hemoglobin proteolysis in the intestine of blood-feeding hookworms. J Biol Chem (2004) 1.41
X-ray structure of Na-ASP-2, a pathogenesis-related-1 protein from the nematode parasite, Necator americanus, and a vaccine antigen for human hookworm infection. J Mol Biol (2005) 1.40
The genome and developmental transcriptome of the strongylid nematode Haemonchus contortus. Genome Biol (2013) 1.37
Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6. Hepatology (2009) 1.37
Gene discovery for the carcinogenic human liver fluke, Opisthorchis viverrini. BMC Genomics (2007) 1.35
The secreted and surface proteomes of the adult stage of the carcinogenic human liver fluke Opisthorchis viverrini. Proteomics (2010) 1.35
Effect of hookworm infection on wheat challenge in celiac disease--a randomised double-blinded placebo controlled trial. PLoS One (2011) 1.30
Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis. Expert Rev Vaccines (2008) 1.30
A novel high throughput assay for anthelmintic drug screening and resistance diagnosis by real-time monitoring of parasite motility. PLoS Negl Trop Dis (2010) 1.28
Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials. Vaccine (2005) 1.28
New technologies for the control of human hookworm infection. Trends Parasitol (2006) 1.27
Proteomics analysis of the excretory/secretory component of the blood-feeding stage of the hookworm, Ancylostoma caninum. Mol Cell Proteomics (2008) 1.26
Suppression of mRNAs encoding tegument tetraspanins from Schistosoma mansoni results in impaired tegument turnover. PLoS Pathog (2010) 1.26
Cloning, yeast expression, isolation, and vaccine testing of recombinant Ancylostoma-secreted protein (ASP)-1 and ASP-2 from Ancylostoma ceylanicum. J Infect Dis (2004) 1.24
Neglected tropical diseases of Oceania: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop Dis (2013) 1.23
Cleavage of hemoglobin by hookworm cathepsin D aspartic proteases and its potential contribution to host specificity. FASEB J (2002) 1.20
Biochemical characterization and vaccine potential of a heme-binding glutathione transferase from the adult hookworm Ancylostoma caninum. Infect Immun (2005) 1.18
Exposed proteins of the Schistosoma japonicum tegument. Int J Parasitol (2009) 1.18
Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm Bowel Dis (2009) 1.17
Characterising the mucosal and systemic immune responses to experimental human hookworm infection. PLoS Pathog (2012) 1.13
Massively parallel sequencing and analysis of the Necator americanus transcriptome. PLoS Negl Trop Dis (2010) 1.12
Molecular characterisation of the Ancylostoma-secreted protein family from the adult stage of Ancylostoma caninum. Int J Parasitol (2003) 1.10
Transcriptional changes in Schistosoma mansoni during early schistosomula development and in the presence of erythrocytes. PLoS Negl Trop Dis (2010) 1.10
Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS One (2011) 1.10
Characterization of the antioxidant enzyme, thioredoxin peroxidase, from the carcinogenic human liver fluke, Opisthorchis viverrini. Mol Biochem Parasitol (2008) 1.08
Vaccination with irradiated Ancylostoma caninum third stage larvae induces a Th2 protective response in dogs. Vaccine (2005) 1.06
Neutralizing antibodies to the hookworm hemoglobinase Na-APR-1: implications for a multivalent vaccine against hookworm infection and schistosomiasis. J Infect Dis (2010) 1.06
Proteases in helminth- and allergen- induced inflammatory responses. Chem Immunol Allergy (2006) 1.06
Cathepsin F cysteine protease of the human liver fluke, Opisthorchis viverrini. PLoS Negl Trop Dis (2009) 1.06
The Human Hookworm Vaccine. Vaccine (2013) 1.05
SBAL: a practical tool to generate and edit structure-based amino acid sequence alignments. Bioinformatics (2012) 1.05
A secreted protein from the human hookworm necator americanus binds selectively to NK cells and induces IFN-gamma production. J Immunol (2004) 1.05
Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths. J Allergy Clin Immunol (2012) 1.05
Ancylostoma caninum MTP-1, an astacin-like metalloprotease secreted by infective hookworm larvae, is involved in tissue migration. Infect Immun (2006) 1.04
Ultrasonography assessment of hepatobiliary abnormalities in 3359 subjects with Opisthorchis viverrini infection in endemic areas of Thailand. Parasitol Int (2011) 1.04
Schistosomiasis vaccine discovery using immunomics. Parasit Vectors (2010) 1.03
Proteolytic degradation of hemoglobin in the intestine of the human hookworm Necator americanus. J Infect Dis (2009) 1.03
Differences in transcription between free-living and CO2-activated third-stage larvae of Haemonchus contortus. BMC Genomics (2010) 1.02
Genetic manipulation of Schistosoma haematobium, the neglected schistosome. PLoS Negl Trop Dis (2011) 1.02
Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2. PLoS Negl Trop Dis (2012) 1.01
Transcriptional changes in the hookworm, Ancylostoma caninum, during the transition from a free-living to a parasitic larva. PLoS Negl Trop Dis (2008) 1.01
Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini. PLoS Negl Trop Dis (2012) 1.00
Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus. Infect Immun (2010) 1.00
Reverse transcriptase activity and untranslated region sharing of a new RTE-like, non-long terminal repeat retrotransposon from the human blood fluke, Schistosoma japonicum. Int J Parasitol (2002) 1.00
Proteomic characterisation of Echinococcus granulosus hydatid cyst fluid from sheep, cattle and humans. J Proteomics (2011) 0.99
The evaluation of recombinant hookworm antigens as vaccines in hamsters (Mesocricetus auratus) challenged with human hookworm, Necator americanus. Exp Parasitol (2007) 0.98
Hookworm excretory/secretory products induce interleukin-4 (IL-4)+ IL-10+ CD4+ T cell responses and suppress pathology in a mouse model of colitis. Infect Immun (2013) 0.98
Retracted Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma. Clin Biochem (2012) 0.97
Infection with the carcinogenic human liver fluke, Opisthorchis viverrini. Mol Biosyst (2011) 0.97
Mobile genetic elements colonizing the genomes of metazoan parasites. Trends Parasitol (2003) 0.97
Changed gluten immunity in celiac disease by Necator americanus provides new insights into autoimmunity. Int J Parasitol (2013) 0.96
Helminth vaccines: from mining genomic information for vaccine targets to systems used for protein expression. Int J Parasitol (2003) 0.96
Genomic-bioinformatic analysis of transcripts enriched in the third-stage larva of the parasitic nematode Ascaris suum. PLoS Negl Trop Dis (2008) 0.95
Asparaginyl endopeptidase from the carcinogenic liver fluke, Opisthorchis viverrini, and its potential for serodiagnosis. Int J Infect Dis (2008) 0.95
Isolation of cDNAs encoding secreted and transmembrane proteins from Schistosoma mansoni by a signal sequence trap method. Infect Immun (2003) 0.94
Hookworm aspartic protease, Na-APR-2, cleaves human hemoglobin and serum proteins in a host-specific fashion. J Infect Dis (2003) 0.94
Effect of vaccinations with recombinant fusion proteins on Ancylostoma caninum habitat selection in the canine intestine. J Parasitol (2002) 0.93
Coming out of the shell: building the molecular infrastructure for research on parasite-harbouring snails. PLoS Negl Trop Dis (2013) 0.92
Schistosoma comparative genomics: integrating genome structure, parasite biology and anthelmintic discovery. Trends Parasitol (2011) 0.92
A deep exploration of the transcriptome and "excretory/secretory" proteome of adult Fascioloides magna. Mol Cell Proteomics (2012) 0.91
Worms and the treatment of inflammatory bowel disease: are molecules the answer? Clin Dev Immunol (2008) 0.91
Effect of vaccination with a recombinant fusion protein encoding an astacinlike metalloprotease (MTP-1) secreted by host-stimulated Ancylostoma caninum third-stage infective larvae. J Parasitol (2003) 0.91
RNA interference targeting cathepsin B of the carcinogenic liver fluke, Opisthorchis viverrini. Parasitol Int (2011) 0.91
Evaluation of liver fluke recombinant cathepsin B-1 protease as a serodiagnostic antigen for human opisthorchiasis. Parasitol Int (2011) 0.90
The hookworm pharmacopoeia for inflammatory diseases. Int J Parasitol (2012) 0.90
Reduction of worm fecundity and canine host blood loss mediates protection against hookworm infection elicited by vaccination with recombinant Ac-16. Clin Vaccine Immunol (2007) 0.89
Ov-APR-1, an aspartic protease from the carcinogenic liver fluke, Opisthorchis viverrini: functional expression, immunolocalization and subsite specificity. Int J Biochem Cell Biol (2008) 0.89
Saposin-like proteins are expressed in the gastrodermis of Schistosoma mansoni and are immunogenic in natural infections. Int J Infect Dis (2008) 0.89
Identification of an astacin-like metallo-proteinase transcript from the infective larvae of Strongyloides stercoralis. Parasitol Int (2005) 0.89
Functional expression and characterization of Echinococcus granulosus thioredoxin peroxidase suggests a role in protection against oxidative damage. Gene (2004) 0.88
A family of cathepsin B cysteine proteases expressed in the gut of the human hookworm, Necator americanus. Mol Biochem Parasitol (2008) 0.88
Ac-SAA-1, an immunodominant 16 kDa surface-associated antigen of infective larvae and adults of Ancylostoma caninum. Int J Parasitol (2004) 0.87
Genomic organization of the Schistosoma mansoni aspartic protease gene, a platyhelminth orthologue of mammalian lysosomal cathepsin D. Gene (2004) 0.87
Hookworm SCP/TAPS protein structure--A key to understanding host-parasite interactions and developing new interventions. Biotechnol Adv (2011) 0.87
The bandit, a new DNA transposon from a hookworm-possible horizontal genetic transfer between host and parasite. PLoS Negl Trop Dis (2007) 0.87
Crystallization and preliminary X-ray analysis of Na-ASP-1, a multi-domain pathogenesis-related-1 protein from the human hookworm parasite Necator americanus. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.86
Molecular characterization of a tetraspanin from the human liver fluke, Opisthorchis viverrini. PLoS Negl Trop Dis (2012) 0.86
The schistosomiasis research agenda--what now? PLoS Negl Trop Dis (2008) 0.86
Short report: Echinococcus granulosus from Xinjiang, PR China: cDNAS encoding the EG95 vaccine antigen are expressed in different life cycle stages and are conserved in the oncosphere. Am J Trop Med Hyg (2003) 0.86
pido, a non-long terminal repeat retrotransposon of the chicken repeat 1 family from the genome of the Oriental blood fluke, Schistosoma japonicum. Gene (2002) 0.86
Venom proteome of the box jellyfish Chironex fleckeri. PLoS One (2012) 0.86
Correlative and dynamic imaging of the hatching biology of Schistosoma japonicum from eggs prepared by high pressure freezing. PLoS Negl Trop Dis (2008) 0.86
Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma. Hum Pathol (2012) 0.86
Characterization of cysteine proteases from the carcinogenic liver fluke, Opisthorchis viverrini. Parasitol Res (2007) 0.86